依达拉奉联合舒血宁治疗出血性脑梗死的临床效果

Clinical effect of edaravone combined with Shuxuening in the treatment of hemorrhagic cerebral infarction

目的 分析依达拉奉联合舒血宁治疗出血性脑梗死的临床效果.方法 选择我院因出血性脑梗死住院治疗的95例患者为研究对象,根据治疗方法的不同将其分为对照组(47例)与观察组(48例),对照组给予依达拉奉治疗,观察组在其基础上联合舒血宁治疗.比较两组的治疗效果.结果 治疗后,观察组的Barthel指数、NIHSS评分均优于对照组(P<0.05).治疗后,观察组的IL-6、IL-1β水平均低于对照组(P<0.05).两组的不良反应总发生率无显著差异(P>0.05).结论 依达拉奉联合舒血宁治疗出血性脑梗死有助于患者神经功能的恢复,可有效提高其日常活动能力,降低炎性因子水平.

Objective To analyze the clinical effect of edaravone combined with Shuxuening in the treatment of hemorrhagic cerebral infarction. Methods Ninety-five patients with hemorrhagic cerebral infarction treated in our hospital were selected as the research objects. According to the different treatment methods, the patients were divided into control group(47 cases) and observation group(48 cases). The control group was given edaravone treatment, and the observation group was combined with Shuxuening treatment on this basis. The therapeutic effects of the two groups were compared.Results After treatment, the scores of Barthel index and NIHSS of the observation group were better than those of the control group(P<0.05). After treatment, the levels of IL-6 and IL-1β in the observation group were lower than those in the control group(P<0.05). There was no significant difference in the total incidence of adverse reactions between the two groups(P>0.05). Conclusion Edaravone combined with Shuxuening in the treatment of hemorrhagic cerebral infarction is helpful to the recovery of nerve function, which can effectively improve the ability of daily activities of patients and reduce the level of inflammatory factors.